Literature DB >> 7523395

In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes.

B M Chowrira1, P A Pavco, J A McSwiggen.   

Abstract

Ribozyme expression cassettes were constructed which generate trimmed, trans-acting ribozymes from longer transcripts through the action of a downstream cis-acting ribozyme. This self-processing system produces small, well-defined trans-acting ribozymes with minimal, nonproductive, intramolecular structure. These cassettes also permit direct comparison of different ribozyme expression vectors without the need to compensate for different transcription initiation and termination sequences. Expression cassettes were created that contain a T7 promoter and that encode a single trans-acting ribozyme followed by either a hammerhead, hairpin, or hepatitis delta virus cis-acting ribozyme. All three ribozyme motifs function efficiently when transcribed in vitro, although slight differences are observed in the efficiency of self-processing for the different motifs. When transiently expressed in cultured mouse cells, the same specific cleavage products are observed. In addition, the relative efficiencies of in vitro self-processing between the three ribozyme constructs was maintained in vivo. Thus, the cellular milieu does not differentially alter the activity of the three ribozyme motifs. Detection of ribozyme-catalyzed RNA cleavage products from cultured cells is direct proof of ribozyme action in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523395

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2.

Authors:  Bruno Da Costa; Christophe Chevalier; Celine Henry; Jean-Claude Huet; Stéphanie Petit; Jean Lepault; Hein Boot; Bernard Delmas
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo.

Authors:  Dominique Lévesque; Sanaa Choufani; Jean-Pierre Perreault
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

3.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

4.  A universal method to produce in vitro transcripts with homogeneous 3' ends.

Authors:  Heike Schürer; Kathrin Lang; Jens Schuster; Mario Mörl
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

5.  Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.

Authors:  Amer Qureshi; Richard Zheng; Terry Parlett; Xiaoju Shi; Priyadhashini Balaraman; Sihem Cheloufi; Brendan Murphy; Christine Guntermann; Peter Eagles
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

6.  Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions.

Authors:  Petra Schlick; Christian Taucher; Beate Schittl; Janina L Tran; Regina M Kofler; Wolfgang Schueler; Alexander von Gabain; Andreas Meinke; Christian W Mandl
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.

Authors:  A M Diegelman; E T Kool
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

8.  Intracellular RNA cleavage by the hairpin ribozyme.

Authors:  A A Seyhan; J Amaral; J M Burke
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

Review 9.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

10.  Dipyridamole reversibly inhibits mengovirus RNA replication.

Authors:  Cori L Fata-Hartley; Ann C Palmenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.